The Center for Advancing Point of Care Technologies (CAPCaT) is actively searching for point-of-care technologies that can be applied to heart, lung, blood or sleep disorders. Entrepreneurs (from anywhere in the world) whose inventions are approaching the clinical testing phase are encouraged to apply for point-of-care grant awards of up to $100,000. The Expression of Interest deadline is Monday, March 2 at 4:59 pm EST.Continue reading
We were delighted to see an SRO crowd of approximately 100 people at our Venture Funding Happy Hour on February 4. This event provided a way for local life science business financing experts to share their expertise with startups. While they offered countless pieces of important advice, the four speakers continued to hammer on one very key piece of information: You need both the science AND someone with the business smarts.Continue reading
In April of 2018, the Indianapolis-based life sciences startup Drug Free Therapeutix (DFTx) was named a winner of the 7th annual M2D2 $200K Challenge. Their innovation: a universal neurostimulation dosing system for pain management. The 2020 Challenge is coming up in March, and because we’re always interested in the progress of past winners, we reached out to DFTx CEO Stephen Hourigan to get an update.Continue reading
Last April, San Francisco-based startup Respirix was named a first-place winner at the 8th annual M2D2 $200K Challenge. Led by CEO Eric Kriegstein, Respirix won the first Boston Scientific Award for their non-invasive cardiac monitor for congestive heart failure patients. With the 2020 Challenge right around the corner, we checked in with Eric to see what’s happened at Respirix over the last year.Continue reading
For the second year, the Deshpande Foundation has announced it will sponsor up to three early-stage India-based life sciences companies that are chosen as finalists in the M2D2 $200K Challenge. This generous sponsorship will cover all travel and housing expenses for those teams, as well as tours around the Massachusetts life sciences innovation ecosystem and introductions to potential mentors and investors.Continue reading
The $200K Challenge is back for its ninth consecutive year! Hosted by M2D2, this event focuses on identifying and rewarding disruptive companies in the medical technology and biotechnology industries. We want to see your innovations brought to life.
Every year we receive scores of entries (nearly 150 in 2019) from life sciences entrepreneurs worldwide. India, China, and Australia are just a few of the many countries involved in the 2019 200K Challenge. Last year, our judges selected 12 winners—a Challenge record!Continue reading
The 2019 Barracuda Bowl will take place on November 6th at the offices of Mintz in Boston. At this event, you’ll have the chance to hear healthcare entrepreneurs pitch their innovations to a panel of investors and learn what investors think of the pitches. You will learn what to expect when you pitch!Continue reading
M2D2 resident companies continue to make news in 2019. In June, Business Insider ranked the 100 most influential and interesting people in the food and drink industry. This list includes other notable names, like Sarah Kauss, founder of S’well, Meghan Markle, and Andy Levitt, founder of Purple Carrot. Abigail Barnes, CEO of Allergy Amulet, was listed at number 22! She was recognized for developing the Allergy Amulet, and the positive impact this food sensor will have for people managing food allergies.Continue reading
Last week, another M2D2 resident company achieved a significant milestone. LaunchPad Medical received approval from the FDA to start a clinical study examing the safety and success of their bone adhesive biomaterial, Tetranite®.
About LaunchPad Medical
LaunchPad Medical, Inc. is primarily involved with the development of an injectable, self-setting osteoconductive bone adhesive material (Tetranite®). While the company’s focus is to use this technology within the dental market, they have also been working on developing adhesive applications for a larger scope of the orthopedics market.Continue reading
M2D2, its resident companies, and the medical device and biotech innovation community in Lowell and Worcester are pleased to welcome RQMIS Inc. as an M2D2 Platinum Corporate Sponsor.
Based in Amesbury, Massachusetts and with sister companies in the UK and Spain, RQMIS provides therapeutically focused, comprehensive regulatory consultation to the global medical device, pharmaceutical, combination product, dietary supplement and human tissue industry. As part of its M2D2 Sponsorship, RQMIS will participate in the $200K Challenge, including the call for applications, applicant screening, and judging the final competition showcase. Regularly throughout the year, RQMIS will offer educational sessions and host office hours to provide mentoring and share insights with M2D2 resident start-up companies.Continue reading